Carcinoma, Intraductal, Noninfiltrating clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for

  • Immunotherapy in High-risk Ductal Carcinoma in Situ (DCIS)

    Sorry, in progress, not accepting new patients

    This is a study to investigate the change in the immune microenvironment of high risk ductal carcinoma in situ (DCIS) after short term exposure to immunotherapy.

    San Francisco, California

Our lead scientists for Carcinoma, Intraductal, Noninfiltrating research studies include .

Last updated: